DENVER, Oct. 05, 2023 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a medical device company developing proprietary solutions…
– Resubmission follows the satisfactory resolution of the FDA’s review of inspection findings at the third-party filler – REDWOOD CITY, Calif.,…
TN-201 is the First Gene Therapy for the Leading Genetic Cause of HCM to be Assessed in Humans; Adds Working…
BMF-219 is a novel covalent menin inhibitor designed to regenerate insulin-producing beta cells with the aim to cure type 1…
BERKELEY, Calif. and MAINZ, Germany, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”),…
ART0380 is a highly competitive, wholly owned ATR inhibitor with broad clinical application alone or in combination for DDR deficient…
Analyst Day will be webcast beginning at 8:30 a.m. ET on Monday, October 16NOVATO, Calif., Oct. 05, 2023 (GLOBE NEWSWIRE)…
InStride Health, in collaboration with McLean Hospital (#1 ranked psychiatric hospital in the US), continues to expand its proven care…
STOCKHOLM, SWEDEN / ACCESSWIRE / October 05, 2023 / Promore Pharma (STO:PROMO)(FRA:8T0)Promore Pharma AB, reg. no. 556639-6809, held an extraordinary…
Innovative product first of its kind to use zero chemicals.NEW YORK, NY / ACCESSWIRE / October 5, 2023 / Fresh…